SCHEMBL257257

SCHEMBL257257

CCCCOc1cc(C(=O)c2ccccc2F)ccc1C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.54
AKR1C3 P42330 1/20 0.48
AKR1C2 P52895 1/20 0.48
AKR1C1 Q04828 1/20 0.48
PTPN11 Q06124 4/20 0.46
RARA P10276 1/20 0.46
RARB P10826 1/20 0.46
PTPN1 P18031 1/20 0.46
CCNB2 O95067 1/20 0.46
CCNE2 O96020 1/20 0.46
CDK1 P06493 1/20 0.46
CDK4 P11802 1/20 0.46
CCNB1 P14635 1/20 0.46
CCND1 P24385 1/20 0.46
CCNE1 P24864 1/20 0.46
CDK2 P24941 1/20 0.46
CCND2 P30279 1/20 0.46
CCND3 P30281 1/20 0.46
CCNB3 Q8WWL7 1/20 0.46
GAA P10253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL257243 0.88 ALDH1A1 (0.48) LMNAAKR1C3AKR1C2AKR1C1CCNB2
SCHEMBL8962222 0.82 CDC25A (0.59) LMNAAKR1C3AKR1C2AKR1C1PTPN11
SCHEMBL1688009 0.81 FAAH (0.52) CCNB2CCNE2CDK1CDK4CCNB1
SCHEMBL10624476 0.81 PTPN11 (0.63) PTPN11RARBALDH1A1
SCHEMBL28193088 0.80 PTPN11 (0.66) PTPN11RARBALDH1A1
SCHEMBL27494596 0.78 PTPN11 (0.68) PTPN11RARBALDH1A1
SCHEMBL9067305 0.78 PTPN11 (0.68) PTPN11RARBALDH1A1
SCHEMBL29994009 0.78 KMT2A (0.69) LMNAPTPN11L3MBTL1HSD17B10KMT2A
SCHEMBL301123 0.78 KMT2A (0.69) LMNAPTPN11L3MBTL1HSD17B10KMT2A
Benzene SCHEMBL28006345 0.78 KMT2A (0.69) LMNAPTPN11L3MBTL1HSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895552-B2 Cyclic amide derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2014-11-25 US disclosed
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2013-08-22 US disclosed
EP-2612848-A1 CYCLIC AMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2013-07-10 EP disclosed
WO-2012029942-A1 CYCLIC AMIDE DERIVATIVE 大日本住友製薬株式会社 (JP) 2012-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE HDAC10, H1-10, H1-0 LMNA 1477/4885AKR1C3 280/4885AKR1C2 324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.